Fingerprint
Dive into the research topics where Rosalie Scholtes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial
Beernink, J. M., Jongs, N., Mosterd, C. M., Scholtes, R. A., Caldwell-McGee, A., Casillas, D., Driscoll, L., Greasley, P. J., Karlsson, C., Hammarstedt, A., Sridhar, V. S., Muskiet, M. H. A., Laverman, G. D., Cherney, D. Z. I., Bjornstad, P., van Raalte, D. H. & Heerspink, H. J. L., Aug 2025, In: Diabetes, Obesity and Metabolism. 27, 8, p. 4415-4426 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Downloads (Pure) -
Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial
van Baar, M. J. B., Muskiet, M. H. A., Scholtes, R. A., Touw, D. J., Nieuwdorp, M., Kramer, M. H. H., Joles, J. A., Cherney, D. Z. I., Bjornstad, P., Krebber, M. M. & van Raalte, D. H., Jul 2025, In: Diabetes, Obesity and Metabolism. 27, 7, p. 3943-3956 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile35 Downloads (Pure) -
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications
León-Jiménez, D., Sridhar, V. S., López-Mendoza, M., Scholtes, R. A., Schmieder, R. E., Cherney, D. Z. I., van Raalte, D. H., Toro-Prieto, F. J., Miramontes-González, J. P. & van Bommel, E. J. M., 1 Jan 2025, In: Clinical kidney journal. 18, 1, sfae370.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile29 Downloads (Pure) -
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
Lytvyn, Y., Scholtes, R. A., Boorsma, E. M., Sridhar, V. S., Kugathasan, L., Liu, H., Lovblom, L. E., Handoko, L., Mosterd, C. M., Floras, J. S., Burns, K., Osuntokun, T., Voors, A., van Raalte, D. H., Heerspink, H. J. L. & Cherney, D. Z. I., 1 Apr 2025, In: Physiological reports. 13, 7, e70275.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile38 Downloads (Pure) -
The systemic and kidney hemodynamic response to empagliflozin, losartan and their combination varies between individuals
Wever, B. E., Scholtes, R. A., Mosterd, C. M., Hesp, A. C., Smits, M. M., Heerspink, H. J. L. & van Raalte, D. H., Jul 2025, In: Journal of nephrology. 38, 6, p. 1647-1653 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile26 Downloads (Pure)